Candid-y Liquid
NDC Package 55714-4843-1
Package Information
Candid-y (adrenalinum, candida albicans, thyroidinum, torula cerevisiae, triticum, ustilago maidis, antimon. crud, arsenicum alb., baptisia, berber. aqui., bryonia, calc. phos., cinchona, helonias dioica, hydrastis, iodium, iris versicolor, kali carb., lachesis, lycopodium, merc. viv., nat.carb., nat. phos, nitricum ac., phosphorus, podoph. pelt, pulsatilla, sepia, echinacea, ginkgo, juglans regia, lappa, thuja occ.) liquids is formulated for associated symptoms such as vaginal itching or discharge, mental fogginess, fatigue, gas and bloating. This formulation utilizes a liquid delivery system. Marketed by Newton Laboratories, Inc., this product is identified by NDC 55714-4843.
Identification & Billing
Clinical Specifications
- ANEMONE PULSATILLA 20 [hp_X]/mL
- ANTIMONY TRISULFIDE 20 [hp_X]/mL
- ARCTIUM LAPPA ROOT 11 [hp_X]/mL
- ARSENIC TRIOXIDE 20 [hp_X]/mL
- BAPTISIA TINCTORIA 20 [hp_X]/mL
- BRYONIA ALBA ROOT 20 [hp_X]/mL
- CANDIDA ALBICANS 20 [hp_X]/mL
- CHAMAELIRIUM LUTEUM ROOT 20 [hp_X]/mL
- CINCHONA OFFICINALIS BARK 20 [hp_X]/mL
- ECHINACEA, UNSPECIFIED 11 [hp_X]/mL
- ELYMUS REPENS ROOT 20 [hp_X]/mL
- ENGLISH WALNUT 11 [hp_X]/mL
- EPINEPHRINE 20 [hp_X]/mL
- GINKGO 11 [hp_X]/mL
- GOLDENSEAL 20 [hp_X]/mL
- IODINE 20 [hp_X]/mL
- IRIS VERSICOLOR ROOT 20 [hp_X]/mL
- LACHESIS MUTA VENOM 20 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 20 [hp_X]/mL
- MAHONIA AQUIFOLIUM ROOT BARK 20 [hp_X]/mL
- MERCURY 20 [hp_X]/mL
- NITRIC ACID 20 [hp_X]/mL
- PHOSPHORUS 20 [hp_X]/mL
- PODOPHYLLUM 20 [hp_X]/mL
- POTASSIUM CARBONATE 20 [hp_X]/mL
- SACCHAROMYCES CEREVISIAE 21 [hp_X]/mL
- SEPIA OFFICINALIS JUICE 20 [hp_X]/mL
- SODIUM CARBONATE 20 [hp_X]/mL
- SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE 20 [hp_X]/mL
- THUJA OCCIDENTALIS LEAFY TWIG 11 [hp_X]/mL
- THYROID, UNSPECIFIED 20 [hp_X]/mL
- TRIBASIC CALCIUM PHOSPHATE 20 [hp_X]/mL
- USTILAGO MAYDIS 20 [hp_X]/mL
- Adrenergic alpha-Agonists - [MoA] (Mechanism of Action)
- Adrenergic beta-Agonists - [MoA] (Mechanism of Action)
- Allergens - [CS]
- Catecholamine - [EPC] (Established Pharmacologic Class)
- Catecholamines - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Dietary Proteins - [CS]
- Fungal Proteins - [CS]
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Food Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Non-Standardized Fungal Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Nut Proteins - [EXT]
- alpha-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
- beta-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
Regulatory & Marketing
Hierarchy Structure
- 55714 - Newton Laboratories, Inc.
- 55714-4843 - Candid-y
- 55714-4843-1 - 30 mL in 1 BOTTLE, GLASS
- 55714-4843 - Candid-y
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 55714-4843-1 identifies a specific commercial package of 30 ml in 1 bottle, glass of Candid-y, a human over the counter drug labeled by Newton Laboratories, Inc.. This liquid is formulated for oral use and contains anemone pulsatilla; antimony trisulfide; arctium lappa root; arsenic trioxide; baptisia tinctoria; bryonia alba root; candida albicans; chamaelirium luteum root; cinchona officinalis bark; echinacea, unspecified; elymus repens root; english walnut; epinephrine; ginkgo; goldenseal; iodine; iris versicolor root; lachesis muta venom; lycopodium clavatum spore; mahonia aquifolium root bark; mercury; nitric acid; phosphorus; podophyllum; potassium carbonate; saccharomyces cerevisiae; sepia officinalis juice; sodium carbonate; sodium phosphate, dibasic, heptahydrate; thuja occidentalis leafy twig; thyroid, unspecified; tribasic calcium phosphate; ustilago maydis as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Newton Laboratories, Inc. on February 01, 2021. The current certification is valid through December 31, 2026.
How is this Newton Laboratories, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 55714484301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.